ALLUNA®

Allgemeine Quellen:

www.aerzteblatt.de/nachrichten/96673/Schlafstoerungen-bei-Jugendlichen-nehmen-zu

www.aerztezeitung.de/politik_gesellschaft/praevention/article/971825/medienkonsum-viele-jugendliche-haben-schlafstoerungen.html

www.gesundheit.de/lexika/medizin-lexikon/schlaf

www.dgsm.de

1. Koetter U et al., A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Phytotherapy Research 2007; 9:847-851
2. Notter D et al., Efficacy and safety of a valerian-hops combination preparation in different sleep disorders. Phytotherapie 2003; 3:9-13
3. Füssel A et al., Effect of a fixed valerian-hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur J Med Res 2000; 5:385-390
4. Lataster MJ et al., Treatment of patients with sleep disorder efficacy and safety of valerian-hops coated tablets (translation). notabene medici 1996:182-185
5. Flesh P et al., Hops-valerian combination as benzodiazepine substitute? Geriatrie Praxis 1997; 1:21-23
6. Kammerer E et al., Influence of a hops-valerian combination on performance ability and traffic safety. Der Bay Int 1996; 3:32-36
7. Sichardt K et al., Modulation of postsynaptic potentials in rat cortical neurons by valerian extracts macerated with different alcohols: involvement of adenosine A1- and GABAA -receptors. Phytotherapy Res 2007; 10:932-937
8. Schellenberg R et al., The fixed combination of valerian and hops (Ze 91019) acts via a central adenosine mechanism. Planta Med 2004; 70:1-5
9. Abourashed EA et al., In vitro binding experiments with a valerian, hops and their fixed combination extract (Ze 91019) to selected nervous system receptors. Phytomedicine 2004; 11:633-638
10. Butterweck V et al., Hypothermic effects of hops are antagonized with the competitive melatonin receptor antagonist luzindole in mice. J of Pharmacy and Pharmacology 2007; 59:549-552
11. Community herbal monograph on Valeriana officinalis L., radix and Humulus lupulus  L., flos. 2011 EMA/HMPC/585558/2007 Corr.
12. Vissiennon Z et al., Valerian extract Ze 911 inhibits postsynaptic potential by activation of adenosine A1 receptors in rat cortical neurons. Planta Med 2006; 72:1-6
13. Dimpfel W et al., Central action of a fixed Valerian-hops extract combination (Ze 91019) in freely moving rats. Eur J Med Res 2006; 11:1-5
14. Muller CE et al., Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors. Life Sci 2002; 71:1939-1949
15. Borbély AA, A Two Process Model of Sleep Regulation. Human Neurobiol 1982; 1:195-204
16. Committee on Herbal Medicinal Products (HMPC), Assessment report on Valeriana officinalis L., radix and Humulus lupulus L., flos. 2010 EMA/HMPC/215214/2008
17. Schumacher B et al., Lignans Isolated from Valerian: Identification and Characterization of a New Olivil Derivative with Partial Agonistic Activity at A1 Adenosine Receptors. J Nat Prod 2002; 65:1479-1485